. 2012 Jun 20;15(3):437–441. doi: 10.1093/icvts/ivs285

Table 1:

Patient characteristics

Patient	Age	Sex	Diagnosis (stage)	Risk factor	Surgery	POD at diagnosis (days)	BT (°C)	Inflammatory marker		MRSA in PE^a	MRSA pneumonia
Patient	Age	Sex	Diagnosis (stage)	Risk factor	Surgery	POD at diagnosis (days)	BT (°C)	WBC	CRP	MRSA in PE^a	MRSA pneumonia
1	67	M	NSCLC (IB)	None	Lobectomy	16	38.2	26.8	26.8	High	No
2	87	M	NSCLC (IB)	HT, TB	Segmentectomy	4	38.6	10.3	15.3	Low	Yes
3	45	M	LD	None	Lobectomy	7	39.3	13.2	32.5	High	No
4	63	F	NSCLC (IA)	None	Lobectomy	18	37.8	16.3	21	Moderate	Yes
5	51	F	NSCLC (IIIA)	None	Lobectomy	15	38.5	10.4	18.6	Moderate	No
6	81	M	MLC	DM	Wedge resection	19	37.8	12.9	9.1	High	No

POD: postoperative day; BT: body temperature at diagnosis; WBC: white blood cells (×10³/µl) at diagnosis; CRP: C-reactive protein (mg/dl) at diagnosis; MRSA: methicillin-resistant Staphylococcus aureus; PE: pleural effusion; M: male; F: female; NSCLC: non-small-cell lung cancer; LD: living lung transplantation donor; MLC: metastatic lung cancer; HT: hypertension; TB: tuberculosis; DM: diabetes mellitus.

^aMRSA concentration in PE at diagnosis of MRSA empyema. High: >50 bacteria per high-power field (magnification ×1000); moderate: 10–50 bacteria per high-power field; low: 1–9 bacteria per high-power field.